CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN)

CUSIP: 23255M105

Q1 2020 13F Holders as of 31 Mar 2020

Holder snapshot 6 signals
Share change
+3,134,853
SEC-reported price per share
$2.65
Number of holders
67
Value change
+$8,211,551
Number of buys
32
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,330,313

Security key

23255M105

Report period

Q1 2020

Institutions

67

Top holders

10

Ownership snapshot

Top reported holders of CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Dec 2019
13F Highest disclosed value: $6,885,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $6.88M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $6.88M
EcoR1 Capital, LLC $4.93M
BlackRock Finance, Inc. $4.4M
MFN Partners Management, LP $4.05M
Artal Group S.A. $3.7M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$6,885,000
2,531,429 shares
— 31 Dec 2019
EcoR1 Capital, LLC
13F
Company
13F
—
denominator unverified
$4,926,000
1,811,000 shares
— 31 Dec 2019
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$4,398,000
1,616,588 shares
— 31 Dec 2019
MFN Partners Management, LP
13F
Company
13F
—
denominator unverified
$4,047,000
1,487,874 shares
— 31 Dec 2019
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$3,703,000
1,361,584 shares
— 31 Dec 2019
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$3,513,000
1,291,625 shares
— 31 Dec 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
67
Shares
18,528,720
Rows available
67
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2020 Across Filers

Q1 2020 holders
67
Q1 2020 holders
67
Holder diff
0
Investor Q1 2020 Shares Q1 2020 Shares Share Diff Share Chg % Q1 2020 value Q1 2020 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .